Flora Bahrami, René Michel Rossi, Katelijne De Nys & Thijs Defraeye. (2023) An individualized digital twin of a patient for transdermal fentanyl therapy for chronic pain management. Drug Delivery and Translational Research 13:9, pages 2272-2285.
Crossref
Yoshio Nakagawa, Jin Suzuki, Toshinari Suzuki, Hideyo Takahashi, Kosho Makino, Yasushi Ono, Miho Sakamoto & Akiko Inomata. (2023) Cytotoxic effects of psychoactive isobutyrylfentanyl and its halogenated derivatives on isolated rat hepatocytes. Journal of Applied Toxicology 43:9, pages 1379-1392.
Crossref
Taryn Bosquez-Berger, Jessica A. Gudorf, Charles P. Kuntz, Jacob A. Desmond, Jonathan P. Schlebach, Michael S. VanNieuwenhze & Alex Straiker. (2023) Structure–Activity Relationship Study of Cannabidiol-Based Analogs as Negative Allosteric Modulators of the μ-Opioid Receptor. Journal of Medicinal Chemistry 66:14, pages 9466-9494.
Crossref
Xuan Luo, Jing Peng, Kejian Huang, Xiaofeng Liu, Ning Yang & Qiulian Luo. (2023) Study on Electron Ionization-Mass Spectrometry Characteristics Fragments and Cleavage Patterns of Fentanyl-type New Psychoactive Substances. Forensic Chemistry, pages 100518.
Crossref
Karam Chamoun, Lucie Chevillard, Aline Hajj, Jacques Callebert & Bruno Mégarbane. (2023) Mechanisms of Neurorespiratory Toxicity Induced by Fentanyl Analogs—Lessons from Animal Studies. Pharmaceuticals 16:3, pages 382.
Crossref
Qian Wang, Jing Dong, Xin Ye & Yi-Feng Ren. (2023) A Meta-Analysis Showing the Quantitative Evidence Base of Preemptive Pregabalin for Postoperative Pain from Cancer-Related Surgery. Medicina 59:2, pages 280.
Crossref
Yu Zhang, John C. Halifax, Christina Tangsombatvisit, Cassandra Yun, Shaokun Pang, Shirin Hooshfar, Alan H.B. Wu & Kara L. Lynch. (2022) Development and application of a High-Resolution mass spectrometry method for the detection of fentanyl analogs in urine and serum. Journal of Mass Spectrometry and Advances in the Clinical Lab 26, pages 1-6.
Crossref
Savitha Racha, Megan Buresh & Michael Fingerhood. (2022) Pharmacotherapy of Opioid Use Disorder—Update and Current Challenges. Psychiatric Clinics of North America 45:3, pages 335-346.
Crossref
Jayashree C. Patel & Suphiya Parveen. (2021) In Vitro and In Vivo Analysis of Fentanyl and Fentalog Metabolites using Hyphenated Chromatographic Techniques: A Review. Chemical Research in Toxicology 35:1, pages 30-42.
Crossref
Sakshi Yadav, Anuj Ajayababu, Tej Prakash Sinha & Sanjeev Bhoi. 2022. Pain Management - From Pain Mechanisms to Patient Care [Working Title]. Pain Management - From Pain Mechanisms to Patient Care [Working Title].
Sierra Ferguson & Aviva Teitelbaum. 2022. Addiction Medicine. Addiction Medicine
67
79
.
Victor W. Weedn, Mary Elizabeth Zaney, Bruce McCord, Ira Lurie & Andrew Baker. (2021) Fentanyl‐related substance scheduling as an effective drug control strategy. Journal of Forensic Sciences 66:4, pages 1186-1200.
Crossref
Ulrike Lorch, Tomasz Pierscionek, Anne Freier, Christopher S. Spencer & Jörg Täubel. (2020) Safety, Tolerability, and Dose Proportionality of a Novel Transdermal Fentanyl Matrix Patch and Bioequivalence With a Matrix Fentanyl Patch: Two Phase 1 Single‐Center Open‐Label, Randomized Crossover Studies in Healthy Japanese Volunteers. Clinical Pharmacology in Drug Development 10:3, pages 260-271.
Crossref
Rebekah E Wharton, Jerry Casbohm, Ryan Hoffmaster, Bobby N Brewer, M G Finn & Rudolph C Johnson. (2021) Detection of 30 Fentanyl Analogs by Commercial Immunoassay Kits. Journal of Analytical Toxicology 45:2, pages 111-116.
Crossref
Jonathan P. Caulkins, Anne GouldBryce Pardo, Peter Reuter & Bradley D. Stein. (2021) Opioids and the Criminal Justice System: New Challenges Posed by the Modern Opioid Epidemic. Annual Review of Criminology 4:1, pages 353-375.
Crossref
Javad Mozafari, Mohammadreza Maleki Verki, Hassan Motamed, Alireza Sabouhi & Fatemeh Tirandaz. (2020) Comparing intranasal ketamine with intravenous fentanyl in reducing pain in patients with renal colic: A double-blind randomized clinical trial. The American Journal of Emergency Medicine 38:3, pages 549-553.
Crossref
Zhao Li, Hui Chen, Sheng Feng, Kengku Liu & Ping Wang. (2020) Development and Clinical Validation of a Sensitive Lateral Flow Assay for Rapid Urine Fentanyl Screening in the Emergency Department. Clinical Chemistry 66:2, pages 324-332.
Crossref
Jacqueline E. Goldman, Katherine M. Waye, Kobe A. Periera, Maxwell S. Krieger, Jesse L. Yedinak & Brandon D. L. Marshall. (2019) Perspectives on rapid fentanyl test strips as a harm reduction practice among young adults who use drugs: a qualitative study. Harm Reduction Journal 16:1.
Crossref
Ying Han, Wei Yan, Yongbo Zheng, Muhammad Zahid Khan, Kai Yuan & Lin Lu. (2019) The rising crisis of illicit fentanyl use, overdose, and potential therapeutic strategies. Translational Psychiatry 9:1.
Crossref
Randy Torralva & Aaron Janowsky. (2019) Noradrenergic Mechanisms in Fentanyl-Mediated Rapid Death Explain Failure of Naloxone in the Opioid Crisis. Journal of Pharmacology and Experimental Therapeutics 371:2, pages 453-475.
Crossref
Joshua D. Weatherston, Shuai Yuan, Chad V. Mashuga & Hung-Jen Wu. (2019) Multi-functional SERS substrate: Collection, separation, and identification of airborne chemical powders on a single device. Sensors and Actuators B: Chemical 297, pages 126765.
Crossref
Alonja Reiter, Alexander Mueller, Benjamin Otto, Sven Anders, Maja Falckenberg, Stefanie Iwersen-Bergmann & Hilke Andresen-Streichert. (2019) Fast increase of postmortem fentanyl blood concentrations after transdermal application: A call to careful interpretation. Forensic Science International 302, pages 109896.
Crossref
Lauren C. Smith, Paul T. Bremer, Candy S. Hwang, Bin Zhou, Beverly Ellis, Mark S. Hixon & Kim D. Janda. (2019) Monoclonal Antibodies for Combating Synthetic Opioid Intoxication. Journal of the American Chemical Society 141:26, pages 10489-10503.
Crossref
Abhijeet Maurya, Srinath Rangappa, Jungeun Bae, Trisha Dhawan, Sankar Srinivas Ajjarapu & S. Narasimha Murthy. (2019) Evaluation of soluble fentanyl microneedles for loco-regional anti-nociceptive activity. International Journal of Pharmaceutics 564, pages 485-491.
Crossref
David H. Cisewski & Sergey M. Motov. (2019) Essential pharmacologic options for acute pain management in the emergency setting. Turkish Journal of Emergency Medicine 19:1, pages 1-11.
Crossref
Jian-Da Lu & Jun Xue. 2019. Critical Care Nephrology. Critical Care Nephrology
600
629.e7
.
Stefano D'Errico. (2018) Commentary. Fentanyl-related death and the underreporting risk. Journal of Forensic and Legal Medicine 60, pages 35-37.
Crossref
S. Mallory Burns, Christopher W. Cunningham & Susan L. Mercer. (2018) DARK Classics in Chemical Neuroscience: Fentanyl. ACS Chemical Neuroscience 9:10, pages 2428-2437.
Crossref
Patil Armenian, Kathy T. Vo, Jill Barr-Walker & Kara L. Lynch. (2018) Fentanyl, fentanyl analogs and novel synthetic opioids: A comprehensive review. Neuropharmacology 134, pages 121-132.
Crossref
C.N. Chatterton & M. Scott-Ham. (2018) The distribution and redistribution of fentanyl & norfentanyl in post mortem samples. Forensic Science International 284, pages 146-152.
Crossref
Laura Hikin, Paul R. Smith, Eleanor Ringland, Simon Hudson & Stephen R. Morley. (2018) Multiple fatalities in the North of England associated with synthetic fentanyl analogue exposure: Detection and quantitation a case series from early 2017. Forensic Science International 282, pages 179-183.
Crossref
Ana Causanilles, Juliet Kinyua, Christoph Ruttkies, Alexander L.N. van Nuijs, Erik Emke, Adrian Covaci & Pim de Voogt. (2017) Qualitative screening for new psychoactive substances in wastewater collected during a city festival using liquid chromatography coupled to high-resolution mass spectrometry. Chemosphere 184, pages 1186-1193.
Crossref
Lisa K. Dr. Freeman, Stacey Bourque, Nick Etches, Karin Goodison, Claire O’Gorman, Kay Rittenbach, Christopher A. Sikora & Mark Yarema. (2017) Alberta’s provincial take-home naloxone program: A multi-sectoral and multi-jurisdictional response to overdose. Canadian Journal of Public Health 108:4, pages 398-402.
Crossref
Joji Suzuki & Saria El-Haddad. (2017) A review: Fentanyl and non-pharmaceutical fentanyls. Drug and Alcohol Dependence 171, pages 107-116.
Crossref
Fang Wu, Matthew H. Slawson & Kamisha L. Johnson-Davis. (2017) Metabolic Patterns of Fentanyl, Meperidine, Methylphenidate, Tapentadol and Tramadol Observed in Urine, Serum or Plasma. Journal of Analytical Toxicology.
Crossref
Shaohua Li, Devora Cohen-Karni, Marina Kovaliov, Nestor Tomycz, Boyle Cheng, Donald Whiting & Saadyah Averick. (2017) Synthesis and biological evaluation of fentanyl acrylic derivatives. RSC Advances 7:32, pages 20015-20019.
Crossref
Ashraf Amlani, Geoff McKee, Noren Khamis, Geetha Raghukumar, Erica Tsang & Jane A. Buxton. (2015) Why the FUSS (Fentanyl Urine Screen Study)? A cross-sectional survey to characterize an emerging threat to people who use drugs in British Columbia, Canada. Harm Reduction Journal 12:1.
Crossref
Ruben S VardanyanVictor J Hruby. (2014) Fentanyl-related compounds and derivatives: current status and future prospects for pharmaceutical applications. Future Medicinal Chemistry 6:4, pages 385-412.
Crossref
D. Adam Algren, Carolyn P. Monteilh, Mohan Punja, Joshua G. Schier, Martin Belson, Bradford R. Hepler, Carl J. Schmidt, Corinne E. Miller, Manish Patel, Leonard J. Paulozzi, Masja Straetemans & Carol Rubin. (2013) Fentanyl-associated Fatalities Among Illicit Drug Users in Wayne County, Michigan (July 2005–May 2006). Journal of Medical Toxicology 9:1, pages 106-115.
Crossref
Asbjørn M. Drewes, Rasmus D. Jensen, Lecia M. Nielsen, Joanne Droney, Lona L. Christrup, Lars Arendt-Nielsen, Julia Riley & Albert Dahan. (2013) Differences between opioids: pharmacological, experimental, clinical and economical perspectives. British Journal of Clinical Pharmacology 75:1, pages 60-78.
Crossref
Michael C. Milone. (2012) Laboratory Testing for Prescription Opioids. Journal of Medical Toxicology 8:4, pages 408-416.
Crossref
Kevin Woodward & Kevin WoodwardK. N. Woodward. 2012. Toxicological Effects of Veterinary Medicinal Products in Humans. Toxicological Effects of Veterinary Medicinal Products in Humans
155
247
.
Donald G. Barceloux. 2012. Medical Toxicology of Drug Abuse. Medical Toxicology of Drug Abuse
539
545
.
Ruth Verplaetse & Jan Tytgat. (2010) Development and validation of a sensitive ultra performance liquid chromatography tandem mass spectrometry method for the analysis of fentanyl and its major metabolite norfentanyl in urine and whole blood in forensic context. Journal of Chromatography B 878:22, pages 1987-1996.
Crossref
Kalen N. Olson, Kristin Luckenbill, Jonathan Thompson, Owen Middleton, Roberta Geiselhart, Kelly M. Mills, Julie Kloss & Fred S. Apple. (2010) Postmortem Redistribution of Fentanyl in Blood. American Journal of Clinical Pathology 133:3, pages 447-453.
Crossref
Nelson M. Lafreniere & James H. Watterson. (2010) Detection of acute fentanyl exposure in fresh and decomposed skeletal tissues part II: The effect of dose–death interval. Forensic Science International 194:1-3, pages 60-66.
Crossref
Bryan Ballantyne. 2009. General, Applied and Systems Toxicology. General, Applied and Systems Toxicology.
G.-H. E. TJAKKES, L. G. M. DE BONT, M. VAN WIJHE & B. STEGENGA. (2009) Classification of chronic orofacial pain using an intravenous diagnostic test. Journal of Oral Rehabilitation 36:7, pages 469-475.
Crossref
Nelson M. Lafrenière & James H. Watterson. (2009) Detection of acute fentanyl exposure in fresh and decomposed skeletal tissues. Forensic Science International 185:1-3, pages 100-106.
Crossref
Dingwei Kuang, Claudio Ronco & Nicholas A. Hoenich. 2009. Critical Care Nephrology. Critical Care Nephrology
931
954
.
Mizuki Hashimoto, Ken Johkura, Teruo Ichikawa, Akio Kojima, Satoshi Nishimura & Masamichi Shinonaga. (2008) Conservative treatment of ruptured vertebrobasilar dissecting aneurysm. Neurological Sciences 29:4, pages 241-244.
Crossref
Kenzie Preston, John Schmittner, David Epstein & Sharon Walsh. 2007. Pharmacokinetics and Pharmacodynamics of Abused Drugs. Pharmacokinetics and Pharmacodynamics of Abused Drugs
143
173
.
Amanda Jenkins. 2007. Pharmacokinetics and Pharmacodynamics of Abused Drugs. Pharmacokinetics and Pharmacodynamics of Abused Drugs
25
63
.
Steven Karch. 2007. Postmortem Toxicology of Abused Drugs. Postmortem Toxicology of Abused Drugs
141
179
.
Jonathan G. Thompson, Andrew M. Baker, Anne H. Bracey, Justin Seningen, Julie S. Kloss, A. Quinn Strobl & Fred S. Apple. (2007) Fentanyl Concentrations in 23 Postmortem Cases from the Hennepin County Medical Examiner?s Office. Journal of Forensic Sciences 52:4, pages 978-981.
Crossref
Elena F. Kranioti, Anna Mavroforou, Panagiotis Mylonakis & Manolis Michalodimitrakis. (2007) Lethal self administration of propofol (Diprivan). Forensic Science International 167:1, pages 56-58.
Crossref
Stephen Heishman. 2006. Drug Abuse Handbook, Second Edition. Drug Abuse Handbook, Second Edition
207
311
.
Amanda Jenkins. 2006. Drug Abuse Handbook, Second Edition. Drug Abuse Handbook, Second Edition
147
205
.
. 2006. Drug Abuse Handbook, Second Edition. Drug Abuse Handbook, Second Edition
1175
1224
.
Rachel Haroz & Michael I. Greenberg. (2006) New Drugs of Abuse in North America. Clinics in Laboratory Medicine 26:1, pages 147-164.
Crossref
Rachel Haroz & Michael I. Greenberg. (2005) Emerging Drugs of Abuse. Medical Clinics of North America 89:6, pages 1259-1276.
Crossref
Mario Thevis, Hans Geyer, Daniel Bahr & Wilhelm Schänzer. (2017) Identification of Fentanyl, Alfentanil, Sufentanil, Remifentanil and Their Major Metabolites in Human Urine by Liquid Chromatography/Tandem Mass Spectrometry for Doping Control Purposes. European Journal of Mass Spectrometry 11:4, pages 419-427.
Crossref
Kyriaki Mystakidou, Emmanuela Katsouda, Efi Parpa, Marinos L. Tsiatas & Lambros Vlahos. (2016) Oral transmucosal fentanyl citrate for the treatment of breakthrough pain in cancer patients: An overview of its pharmacological and clinical characteristics. American Journal of Hospice and Palliative Medicine® 22:3, pages 228-232.
Crossref
Asim F. Tarabar & Lewis S. Nelson. (2003) The resurgence and abuse of heroin by children in the United States. Current Opinion in Pediatrics 15:2, pages 210-215.
Crossref
D de Boer, W.-P.J Goemans, V.R Ghezavat, R.D van Ooijen & R.A.A Maes. (2003) Seizure of illicitly produced para-fluorofentanyl: quantitative analysis of the content of capsules and tablets. Journal of Pharmaceutical and Biomedical Analysis 31:3, pages 557-562.
Crossref
Mark D ReevesCorinne J Ginifer. (2002) Fatal intravenous misuse of transdermal fentanyl. Medical Journal of Australia 177:10, pages 552-554.
Crossref
Karel Valter & Philippe Arrizabalaga. 1998. Designer Drugs Directory. Designer Drugs Directory
147
151
.
Robert Kronstrand, Henrik Druid, Per Holmgren & Jovan Rajs. (1997) A cluster of fentanyl-related deaths among drug addicts in Sweden. Forensic Science International 88:3, pages 185-195.
Crossref
Leslie E. EdinboroAlphonse PoklisDonna TrautmanSybil LowryRonald BackerCharles M. Harvey. (1997) Fatal Fentanyl Intoxication Following Excessive Transdermal Application. Journal of Forensic Sciences 42:4, pages 14196J.
Crossref
Paul LI Dellemijn & Jan AL Vanneste. (1997) Randomised double-blind active-placebo-controlled crossover trial of intravenous fentanyl in neuropathic pain. The Lancet 349:9054, pages 753-758.
Crossref
A.I.L. Berens, A.J. Voets & P. Demedts. (1996) Illicit fentanyl in Europe. The Lancet 347:9011, pages 1334-1335.
Crossref